Skip to main content
. 2021 Jan 22;273:113871. doi: 10.1016/j.jep.2021.113871

Fig. 3.

Fig. 3

Drug-compound-target-pathway interactions for RDNI. Nodes in purple represent the compound; nodes in green and yellow represent the targets, nodes in yellow represent the targets that are co-expressed with ACE2, and the nodes in blue represent the potential pathways. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)